Research Journal of Pharmacology and Pharmacodynamics

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

The Occurrence of Hepatitis B Virus amongst Blood Donors Attending the Bamenda Regional Hospital


Affiliations
1 Department of Medical Biochemistry, St. Louis University Institute of Health and Biomedical Sciences, Mile III Nkwen, Bamenda, Cameroon
     

   Subscribe/Renew Journal


Hepatitis B virus is a major cause of liver disease worldwide and the infection may go unnoticed because more than 50% of the cases are asymptomatic. Infected people therefore either unconsciously contribute to the transmission of the virus or do not seek medical attention resulting in liver cirrhosis or hepatocellular carcinoma. This study therefore evaluated the occurrence of HBV amongst blood donors attending the Bamenda Regional Hospital. This cross - sectional hospital based study involved 100 blood donors who randomly selected to participate. Screening for HBV was done using the One Step Hepatitis B Surface Antigen Test Strip (DiaSpot). From the results, the prevalence of HBV was found to be 14.0%. Majority of the participants were males (83.0%) within the age range of 25 - 31 years (35.0%). Also from the positive cases of HBV identified, majority of them were male replacement donors (12.0%) who were within the age range of 25 - 31 years (6.0%) and were singles (8.0%). In conclusion, the prevalence of HBV in this study was high (14.0%) with the highest prevalence amongst male replacement donors within the age range of 25 - 31 years.

Keywords

Hepatitis B Virus, Blood Donors, Bamenda, Regional Hospital.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Ado, A., Alhassan, S., Chonoko, U.G and Samaila, A.U (2008). Sero – prevalence of Hepatitis B surface antigen (HBsAg) amongst blood donors. Bayero Journal of Pure and applied sciences. 3(1):20-22.

  • Arauz – Ruiz, P., Nordoer, H., Robertson, B.H and Magnius, L.O (2002). Genotypes H, a new Amerindian genotype of hepatitis virus: complete genome and phylogenetic relatedness. J. Gen Virol 16:64–73.

  • Chu, C.J., Keeffe, E.B., Han, S.H., Perrillo, R.P., Min, A.D., Soldevila – Pico., Carey, W., Brown, R.S., Luketic, V.A., Terrault, N and Lok, A.S (2003). Hepatitis B virus genotypes in the United States. Gastroenterology 125: 444–451.

  • Diarra, A., Kouriba, B., Baby, M., Murphy, E and Lefrere, J.J (2009). HIV, HBV, HCV and syphilis rate of positive donations among blood donors. Transfusion Clinique et Biologique. 16:144–44.

  • Dominque, N.N., Richard, N., Aime, B.P., Persou, J., Meli, M and Biwole, S (2011). Hepatitis B surface antigene prevalence in blood donors and the risk of transfusion of hepatitis B. Journal of Gastroenterology. 1: 23–27.

  • Friss, R and Steller, T (2004). Epidemiology for Public Health Practice. Jones and Bart Lett publishers London.Chapter 12.

  • Julius, T.F., Sylvanus K., Ireneous, N.S., Patrick, N.A., Juventus, B.Z and Kenneth, S (2012). Prevalence of hepatitis B virus infection amongst blood donors. BMC research notes. 5: 115.

  • Kidd – Ljunggren, K., Holmberg, A., Blackberg, J and Lindqvist, B (2006). High levels of hepatitis B virus DNA in body fluids from chronic carriers. Journal of Hospital Infection. 64(4): 352–7.

  • Lavanya, V., Viswanathan, T., Arul, S., Malarvizhi, A and Moorthy, K (2012). Prevalence of hepatitis viral infection amongst blood donors with antibodies to hepatitis B core antigen. International journal of Medicine and Medical Sciences vol.4(6): 128–137

  • Mathers, C.D and Lancer, D (2002). Projections of global mortality and burden of disease. Plos Medicine. 3: 512.

  • N'guessan, N., Thot'o, A.S., Okon, A.J.B., Emile, C.A., Soro, D., Mamadou, A.D., Kone, K., Siaka, M., Jeanne, B.M and Camara (2013). Prevalence of HBsAg amongst blood donors in transfusion center, Abidjan. Journal of Gastroenterology. 3: 165-169

  • Panessa, G.R., Nwachukwu, O. Ishaleku, D and Omugadu, R.J (2011). Hepatitis B virus carriage amongst students of a Nigerian Tertiary Institution: A cohort of Eligible blood donors. Research Journal of Medical sciences. 5(2): 90–93.

  • Schaefer, S (2007). Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J. Gastroenterol. 13: 14–21.

  • Sleisenger, M.H., Feldma, M and Friedman, L.S (2006). Fordtrans's gastrointestinal and liver disease: pathophysiology, diagnosis and management 8

  • th ed. Philadelphia: Saunders.

  • Soriano, V., Barreiro, P and Nunez, M (2006). Management of chronic hepatitis B and C virus HIV co–infected patients. J. Antimicrob Chemother. 57: 815–818 World Health Organization (2013). Hepatitis: frequently asked questions.


Abstract Views: 404

PDF Views: 0




  • The Occurrence of Hepatitis B Virus amongst Blood Donors Attending the Bamenda Regional Hospital

Abstract Views: 404  |  PDF Views: 0

Authors

Emmanuel N. Tufon
Department of Medical Biochemistry, St. Louis University Institute of Health and Biomedical Sciences, Mile III Nkwen, Bamenda, Cameroon
A. Nji Nancy
Department of Medical Biochemistry, St. Louis University Institute of Health and Biomedical Sciences, Mile III Nkwen, Bamenda, Cameroon
N. Ndonhui Noel
Department of Medical Biochemistry, St. Louis University Institute of Health and Biomedical Sciences, Mile III Nkwen, Bamenda, Cameroon

Abstract


Hepatitis B virus is a major cause of liver disease worldwide and the infection may go unnoticed because more than 50% of the cases are asymptomatic. Infected people therefore either unconsciously contribute to the transmission of the virus or do not seek medical attention resulting in liver cirrhosis or hepatocellular carcinoma. This study therefore evaluated the occurrence of HBV amongst blood donors attending the Bamenda Regional Hospital. This cross - sectional hospital based study involved 100 blood donors who randomly selected to participate. Screening for HBV was done using the One Step Hepatitis B Surface Antigen Test Strip (DiaSpot). From the results, the prevalence of HBV was found to be 14.0%. Majority of the participants were males (83.0%) within the age range of 25 - 31 years (35.0%). Also from the positive cases of HBV identified, majority of them were male replacement donors (12.0%) who were within the age range of 25 - 31 years (6.0%) and were singles (8.0%). In conclusion, the prevalence of HBV in this study was high (14.0%) with the highest prevalence amongst male replacement donors within the age range of 25 - 31 years.

Keywords


Hepatitis B Virus, Blood Donors, Bamenda, Regional Hospital.

References